The proposal, to invest in new and modern hospital facilities, will resolve the challenge the hospital faces on a day-to-day basis – providing 21st century care from 19th century buildings.
The plan would bring all the hospital's services and clinical experts under one roof and provide patients with a state-of-the-art hospital that promotes faster recovery. This includes an increased number of single occupancy rooms, essential for those with chronic diseases like cystic fibrosis who are at greater risk of potentially life-threatening infections. Bringing all clinical services together on a single site also removes the current need to transport patients by ambulance between buildings, which can disrupt their care.
-- Advertisement --
The investment will secure the Hospital Trust's position as the UK's leading specialist centre for heart and lung disease. It will benefit thousands of current and future patients who receive lifelong specialist care for their complex conditions. Further integration of pioneering research and teaching, alongside clinical care, will lead to innovations in treatment that directly improve the health of patients in the UK and across the world.
An improved working environment, which supports the future growth of clinical activity and is able to respond to new technological developments, will help attract and retain the world’s top clinicians specialising in heart and lung disease.
Bob Bell, CEO Royal Brompton & Harefield NHS Foundation Trust, said: "Matching world-class clinicians with world-class facilities will undoubtedly benefit the patients who come to Royal Brompton Hospital from the UK and around the world for lifesaving treatment.
"This capital investment is absolutely essential as it becomes increasingly difficult to continue providing high-quality patient care from some of our current buildings which are over 170 years old.
"It will enable us to consolidate our services on one site, streamlining the day-to-day running of the hospital and making it easier for patients to access the best possible clinical care and sophisticated technology in one place. It will provide a hospital environment that supports innovation and cutting-edge research, to ensure continued and exciting advancements in the treatments available for heart and lung disease."
(CD/IT)
